About ISOLOGIC

Isologic Innovative Radiopharmaceuticals (ISOLOGIC) is a Canadian company dedicated to nuclear medicine and a leader in the production and delivery of high-quality radiopharmaceuticals through our network of SPECT radiopharmacies and PET manufacturing facilities.

mission icon

Our Mission

To deliver the most clinically relevant PET and SPECT radiopharmaceuticals in a safe and reliable manner allowing Canadian physicians to accurately diagnose, manage and treat disease.

vision icon

Our Vision

Isologic will strengthen its position as Canada’s leading radiopharmaceutical provider by expanding its geographic reach, fostering strong customer relationships, and driving innovation and research. Through operational excellence and strategic partnerships, we will strive to be Canada’s gateway for novel radiopharmaceuticals, ensuring patient access to novel diagnostic and therapeutic solutions for all Canadians. 

Our values ​​guide our daily actions and decisions.

people-icon

People First

We are committed to fostering a culture of care and respect for our employees while prioritizing the needs of our customers, and their patients.

quality-icon

Quality

We uphold the highest standards of quality in everything we do.

Ethics

Ethics

We act with the utmost transparency and integrity.
acountability-icon

Accountability

We take responsibility for our actions and the impact we have on patients.

Health and Safety

Health and Safety

We focus on implementing measures that ensure the health and safety of our employees, customers and patients.

collaboration

Collaboration

We are committed to teamwork and clear communication while transcending organizational and geographical boundaries.

Innovation

Innovation

We continuously innovate to improve production methods and efficiency to surpass customer expectations.

president André Gagnon

A message from the President

ISOLOGIC has taken a leadership position in supplying the Canadian nuclear medicine community with clinically relevant radiopharmaceuticals. Our proven success in developing and commercializing innovative imaging agents provides strong evidence of our willingness to bring forward breakthrough radiopharmaceuticals to market.

With state-of-the-art facilities across Canada, and strategic alliances with world-renowned university research hospitals and Nuclear Medicine experts, ISOLOGIC is ready to expand its offering to include the next generation of PET and SPECT radiopharmaceuticals and provide nuclear medicine centres with the most effective diagnostic tools to improve patient care.

andre signature

André Gagnon

Trusted Quality Care

At Isologic, we offer healthcare professionals peace of mind by ensuring high standards, extensive expertise, and proactive supply management. With over 600,000 doses delivered annually, we guarantee fast, compliant, and reliable service, even during supply shortages.

Our passion drives us to operate 24/7, with a dedicated logistics team and trained professionals who prioritize your needs. We tailor our services to your practice, drawing on deep industry expertise to anticipate and meet the changing needs of clients and patients.

We are committed to delivering high-quality radiopharmaceuticals through rigorous safety protocols, innovative technology, and validated processes. As a trusted partner, we uphold 200+ safety procedures, ensuring every dose meets the highest standards for patient care and clinical excellence.

 

Leadership team

3
David Paradis

David Paradis
Vice-President Finance

Annette Proulx

Annette Proulx
Vice-President of Operations

Frank-Maiorino

Frank Maiorino
Vice-President
Commercial Operations

Jeanne-Yaourtsakis

Jeanne Yaourtsakis
Vice-President Human Resources

Vasa-Sindolic

Vasa Sindolic
Senior Director Cyclotron
and Engineering

Stephane-Martin

Stephane Martin
Sr. Director of CMC / Quality & New
Products Development

Private Sector Partners

3
life-molecular
Telix
avid-logo
belpharma
curium
iba
re-elit
lantheus
point-biopharma
Novartis
Bayer
HIC
GE Health Care
BWXT
Jubilant
international isotopes
Lilly

Public Sector Partners

3
Centre Hospitalier de l’Université de Montréal
The Ottawa Hospital
Sunnybrook Hospital
Vancouver General Hospital

Association Affiliations

3
CNIC
CANM
AMSMNQ
SNMMI
MorePETs
CAMRT